Keyphrases
Cervical Cancer
86%
Gene Fusion
78%
Structural Variation
72%
Sequence Reads
56%
Sequence Data
56%
RNA Sequencing (RNA-seq)
53%
Tumor
42%
Split-read Mapping
37%
Low Coverage
35%
Prostate Cancer
29%
Genotype
27%
RNA Expression
26%
Patient-derived Xenograft
25%
Radiation Therapy
25%
Genomic Characterization
25%
Cervical Cancer Cells
24%
Chemoradiation
23%
SerpinB3
23%
Squamous Cell Carcinoma Antigen
23%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
23%
Estrogen Receptor 1 (ESR1)
23%
Mapping Method
23%
Transcriptome
22%
Small Interfering RNA (siRNA)
22%
Overall Survival
22%
Breast Cancer
21%
Transcriptomic Data
21%
Gene Expression
20%
Transcriptome Analysis
20%
Cancer-related
19%
Improved Outcomes
18%
Rare Variants
17%
Standardized Uptake Value
17%
Computational Approach
17%
Gene Expression Analysis
17%
Outcome Prediction
17%
Chemoradiotherapy
17%
Radiotherapy
16%
Myeloid-derived Suppressor Cells
16%
Next-generation Sequencing Data
16%
Allele Frequency
15%
HPV Genotyping
15%
Metastatic Tumor
15%
Statistical Test
15%
Radiosensitization
15%
Xenograft
15%
Whole Transcriptome
15%
Radiation Effects
15%
Focal Region
15%
Long Non-coding RNA (LncRNA)
15%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Gene Fusion
78%
Indel
59%
Transcriptome
50%
RNA Sequencing
45%
RNA Sequence
44%
RNA
43%
Cancer Cell
41%
Gene Expression Profiling
41%
Overall Survival
39%
Genotyping
38%
Exome
35%
Genetic Divergence
32%
Estrogen Receptor
25%
Genetics
24%
Myeloid
23%
Next Generation Sequencing
22%
Genetic Variation
20%
YAP1
20%
Gene Expression
19%
Small RNAs
19%
T Cell
17%
Non-Coding RNA
17%
Metabolic Pathway
15%
Gene Frequency
14%
P53
14%
Drive
14%
Tumor Progression
14%
Rare Variant
11%
Endogenous Retrovirus
11%
Radiosensitivity
11%
Glutaminase
11%
Clonal Evolution
11%
Mesenchymal-Epithelial Transition
11%
Cathepsin L
11%
Cell Death
11%
Isoform
11%
Bromodomain
11%
Chemokine
11%
Reprogramming
11%
Epigenetics
11%
Human Papillomavirus Type 16
11%
Ligand Binding Domain
11%
Drug Resistance
11%
Oxidative Stress
11%
Gene Amplification
11%
Radiosensitization
11%
Androgen Receptor
11%
Glutamine
11%
Genetic Drift
11%
Medicine and Dentistry
Cervical Cancer
93%
Neoplasm
69%
Radiation Therapy
42%
Cancer Cell
36%
Chemoradiotherapy
33%
Metastatic Carcinoma
29%
RNA Sequencing
26%
Gene Fusion
25%
Prostate Cancer
23%
Squamous Cell Carcinoma Antigen
23%
Overall Survival
23%
Transcriptome
19%
Tumor Progression
17%
Biological Marker
16%
Diseases
15%
Fluorodeoxyglucose F 18
15%
Standardized Uptake Value
15%
Prognosis
15%
Uterine Cervix Carcinoma
14%
Macrophage
14%
CDK4/6 Inhibitor
13%
Cancer Research
13%
Gene Expression
13%
Endogenous Retrovirus
11%
Fatty Acid
11%
Wart Virus
11%
Chemokine
11%
Tumor Resistance
11%
Lymph Duct
11%
Medulloblastoma
11%
Ovarian Cancer
11%
Minimal Residual Disease
11%
Prognostication
11%
Metastatic Breast Cancer
11%
Immunotherapy
11%
T-Cell Response
11%
RNA Sequence
11%
Estrogen Receptor Positive Breast Cancer
11%
Hormone Therapy
11%
Cathepsin L
11%
Fibrolamellar Hepatocellular Carcinoma
11%
Immunity
11%
Oropharynx Carcinoma
11%
Neutrophil
11%
Tamsulosin
11%
Fructose
11%
Breast Cancer
11%
Lysophosphatidylcholine
10%
Primary Tumor
9%
Recurrent Disease
9%
